COVID May Age Blood Vessels by 5 Years, With Stronger Impact in Women: Study

New Delhi, August 19, 2025 — SARS-CoV-2 infection can accelerate the ageing of blood vessels by roughly five years, with the effect more pronounced in women and in people reporting Long COVID symptoms, according to a large international study published in the European Heart Journal. Researchers report higher arterial stiffness after infection, a change linked to future risks such as hypertension, stroke and heart attack. Medical DailyPMCEuropean Society of Cardiology

What the study found

The CARTESIAN (Covid-19 ARTErial StIffness and vascular AgeiNg) collaboration analysed vascular ageing markers in participants who had recovered from COVID-19 and compared them with uninfected controls. The team observed a clinically meaningful rise in arterial stiffness, translating to an estimated ~5-year increase in “vascular age”. Effects were strongest in women and those with persistent post-COVID symptoms, though stiffness tended to stabilise or improve over time in follow-up assessments. Medical DailyPMC

Why it matters

Arterial stiffness reflects endothelial injury and inflammation. When it increases, the heart works harder to push blood through the body, raising long-term cardiovascular risk. The findings add a vascular explanation for the elevated rates of blood pressure spikes, dysautonomia and microthrombotic events that clinics have documented after infection. For health systems, the signal is clear: screen recovered patients—especially women—for heart and vascular risk, and offer targeted prevention. PMC

How robust is the evidence?

CARTESIAN was conceived early in the pandemic as a multi-country, harmonised study using standardised arterial stiffness measurements (e.g., pulse wave velocity). Its protocol and trial registration pre-specified endpoints, centres and methods, strengthening the quality of its evidence base. ResearchGateClinicalTrials

Clinical takeaways (India focus)

  • Prioritise vascular checks after COVID—blood pressure, lipids, HbA1c and, where feasible, arterial stiffness estimates in high-risk groups.

  • Counsel women who had moderate–severe COVID or persistent symptoms about heart-healthy routines and red-flag signs (resting tachycardia, exertional chest discomfort, unexplained fatigue).

  • Manage risk factors early with lifestyle, appropriate medications and follow-up, since stiffness may partially recede over time with recovery and control of inflammation. Medical Daily  

Expert context

Cardiology societies have warned since 2021 that COVID-19 can disrupt the endothelium and speed “early vascular ageing.” The new analysis adds scale and sex-specific detail, prompting calls for post-infection cardiovascular surveillance in national programmes

Related Posts

72-Year-Old Saved by Valve-in-Valve TAVI at Apollo

Bengaluru, August 19, 2025 — A multidisciplinary team at Apollo Hospitals, Bengaluru saved the life of a 72-year-old woman with a dangerous aortic aneurysm by performing a valve-in-valve transcatheter aortic…

Afghan Health System Near Collapse Amid Aid Cuts

New Delhi, August 19, 2025 — Afghanistan’s public-health network is buckling as donor funding dries up, forcing hundreds of clinics to shut and leaving women and children at severe risk,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Controlled substances charge: Court summons Ramdev, Amazon founder

Controlled substances charge: Court summons Ramdev, Amazon founder

Allahabad HC refuses to quash case against pharma company linked to cough syrup deaths in Uzbekistan

Allahabad HC refuses to quash case against pharma company linked to cough syrup deaths in Uzbekistan

IPC registers 44 small-scale medtech firms under ADRMS

IPC registers 44 small-scale medtech firms under ADRMS

Over 9,000 deaths due to respiratory diseases in Delhi

Over 9,000 deaths due to respiratory diseases in Delhi